Chang Gung University
Taoyuan City, 333, Taiwan
NCT Number: NCT03883256
Ventilation limitation has a significant adverse effects on cardiovascular function and cerebral oxygenation during exercise in patients with COPD. High flow nasal cannula (HFNC) has been shown to improve ventilation by washing out the anatomical dead space and permitting a better gas exchanges. Moreover, it is able to ensure the desired inspired oxygen fraction (FiO2) even at high level of patient's minute ventilation by minimizing the room air entrainment. The effects of HFNC on exercise performance in terms of hemodynamic changes and exercise endurance in COPD patients remain unclear. The primary purpose of this study is to examine the effects of HFNC on the exercise endurance in COPD patients. The investigator's secondary purpose is to investigate whether HFNC could improve efficiency of ventilation, leading to an improvement of hemodynamic and cerebral oxygenation response.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Taoyuan City, 333, Taiwan
This is a randomized crossover study. Patients who have been diagnosed as COPD will be recruited from outpatient department. After signing informed consent form, patients undertake an incremental exercise test and two constant load exercise at the 70% of maximum workload achieved at a previous incremental exercise test on arm ergometer in two separate days. The constant load tests will be performed with HFNC and with nasal cannula at the same inhaled oxygen fraction in random order. The hemodynamics CO, SV, EF of all subjects during exercises will be measured by a bioelectrical impedance device (Physioflow), and cerebral oxygenation status (oxygenated hemoglobin (O2Hb), deoxygenated hemoglobin (HHb), total hemoglobin (tHb) was measured by a near infrared spectrophotometer (NIRS).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
High flow nasal cannula is a device that delivered heated and humidified high flow gases to at or near body temperature to avoid drying and possible injury to the nasal mucosa. In this study, subjects perform a constant-load exercise test with high flow nasal cannula.
Nasal cannula is a device that delivered oxygen to patients. In this study, subjects perform a constant-load exercise test with nasal cannula.
Time frame: end of the exercise test in the session of constant-load exercise test with high flow nasal cannula oxygen device
the total duration that subjects performed constant-load exercise test with high flow nasal cannula oxygen device
Time frame: end of the exercise test in the session of constant-load exercise test with nasal cannula oxygen device
the total duration that subjects performed constant-load exercise test with nasal cannula oxygen device
Time frame: Baseline and 48 hours after baseline ]
Difference in end-exercise cardiac output in constant-load exercise test between HFNCO and NC
Time frame: Baseline and 48 hours after baseline ]
Difference in end-exercise stroke volume in constant-load exercise test between HFNCO and NC
Time frame: Baseline and 48 hours after baseline ]
Difference in end-exercise muscle tissue oxygenation in constant-load exercise test between HFNCO and NC
Time frame: Baseline and 48 hours after baseline ]
Difference in end-exercise cerebral tissue oxygenation in constant-load exercise test between HFNCO and NC
Chang Gung University
Other
Effects of High Flow Nasal Cannula on Exercise Endurance in Patients With COPD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial DetailsNCT04754490
COPD, Chronic Disease
Abercynon, Wales, United Kingdom
View Trial DetailsNCT06336252
Arthritis, Basal Ganglia Diseases
Copenhagen, Denmark
View Trial Details